Skip to main content

Kestra Medical Technologies, Lt (KMTS) Stock Analysis

Range Bound setup

SellVALUE-TRAP 2/5Moderate Confidence

Healthcare · Medical Instruments & Supplies

Sell if holding. Engine safety override at $20.01: Quality below floor (3.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.9/10. Specifically: High short interest: 12%; Below-average business quality; Negative price momentum.

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and... Read more

$20.01+20.5% A.UpsideScore 4.9/10#19 of 25 Medical Instruments & Supplies
Stop $18.61Target $24.11(analyst − 13%)A.R:R 1.4:1
Analyst target$27.71+38.5%7 analysts
$24.11our TP
$20.01price
$27.71mean
$17
$30

Sell if holding. Engine safety override at $20.01: Quality below floor (3.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.9/10. Specifically: High short interest: 12%; Below-average business quality; Negative price momentum. Chart setup: RSI 60 mid-range, Bollinger mid-band. Score 4.9/10, moderate confidence.

Passes 5/7 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity 88d clear, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.

Val4.9Qual3.3Grw10.0Mom2.1Sent6.3Ins4.2Peer2.5Tech5.2Risk4.04.9OVERALL

Thesis

Rewards
No bull case signals
Risks
Quality below floor (3.3 < 4.0)
Value-trap signals (2/5): High leverage (D/E 1.7), Material insider selling (18 sells, 0.17% of cap)

Key Metrics

P/E (TTM)—
P/E (Fwd)-9.1
Mkt Cap$1.1B
EV/EBITDA-6.6
Profit Mgn-173.0%
ROE-92.7%
Rev Growth62.7%
Beta—
DividendNone
Rating analysts13

Quality Signals

Piotroski F6/9

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

3 floor-breakers·1 ceiling hit

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Volume
0.0
Obv
1.0
Ma Position
2.2
Macd
2.7
Rsi
4.5
Volume distribution (falling OBV)Below 200-MA but MA still rising (+2.1%/30d) — pullback in uptrend, not confirmed weakness

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
0.0
Value Rank
0.4
Growth Rank
9.5
Industry growth leader

Unprofitable operations — net margin -173.0%. Quality floor flags this regardless of sector context.static

Roe
0.0
Roa
0.0
Fcf Quality
0.0
Moat
5.0
Current Ratio
5.7
Gross Margin
5.8
Piotroski F
6.7
Cash-burning: FCF -89% of revenueNo competitive moat
GatesMomentum 2.1<4.5A.R:R 1.4 < 1.5@spotInsider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 88d clearSEMI CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
60 · Neutral
↓ 20D MA↓ 50D MA↓ 200D MADEATH CROSSSupport $17.34Resistance $24.52

Price Targets

$19
$24
A.Upside+20.5%
A.R:R1.4:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (3.3 < 4.0)
! Value-trap signals (2/5): High leverage (D/E 1.7), Material insider selling (18 sells, 0.17% of cap)
! Momentum score 2.1/10 — below 4.5 minimum

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-27 (88d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is KMTS stock a buy right now?

Sell if holding. Engine safety override at $20.01: Quality below floor (3.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.9/10. Specifically: High short interest: 12%; Below-average business quality; Negative price momentum. Chart setup: RSI 60 mid-range, Bollinger mid-band. Prior stop was $18.61. Score 4.9/10, moderate confidence.

What is the KMTS stock price target?

Take-profit target: $24.11 (+20.5% upside). Prior stop was $18.61. Stop-loss: $18.61.

What are the risks of investing in KMTS?

Quality below floor (3.3 < 4.0); Value-trap signals (2/5): High leverage (D/E 1.7), Material insider selling (18 sells, 0.17% of cap).

Is KMTS overvalued or undervalued?

Kestra Medical Technologies, Lt trades at a P/E of N/A (forward -9.1). TrendMatrix value score: 4.9/10. Verdict: Sell.

What do analysts say about KMTS?

13 analysts cover KMTS with a consensus score of 4.3/5. Average price target: $28.

What does Kestra Medical Technologies, Lt do?Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on...

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Related stocks: MMSI (Merit Medical Systems, Inc.) · STVN (Stevanato Group S.p.A.) · ATRC (AtriCure, Inc.) · SOLV (Solventum Corporation) · NVST (Envista Holdings Corporation)